Plamotamab (XmAb^®13676) for Ibrutinib- refractory CXCR4-mutated extramedullary Waldenström macroglobulinemia

Waldenstrom macroglobulinemia (WM) is an indolent, IgM-producing lymphoproliferative disorder that represents 1–2% of all non-Hodgkin lymphomas (NHL) [1]. High-risk patients, as defined by the inte...